Operator: Good morning and welcome to the BioCryst Second Quarter 2023 Earnings Call. [Operator Instructions] Please note this event is being recorded.
Keep Reading →
August 4 - News, Transcripts
In this piece, we will take a look at the five best medical stocks under $10.
Keep Reading →
June 24 - News
Operator: Good morning and welcome to the BioCryst Q1 2023 Earnings Conference Call. Please note this event is being recorded.
Keep Reading →
May 4 - News, Transcripts
Operator: Good morning and welcome to the BioCryst Fourth Quarter 2022 Earnings Conference Call. Please note this event is being recorded.
Keep Reading →
February 23 - News, Transcripts
In this article, we will take a look at the 5 best buy-the-dip stocks to buy now.
Keep Reading →
December 28 - Hedge Funds, News
In this article, we discuss 5 best small-cap healthcare stocks to buy now.
Keep Reading →
December 12 - Hedge Funds, News
In this article, we discuss the 5 biggest small-cap stocks in the Ken Fisher portfolio.
Keep Reading →
November 17 - Hedge Funds, News
In this article, we discuss 5 small-cap stocks to buy according to Ken Fisher.
Keep Reading →
June 30 - Hedge Funds, News
In this article, we present the 10 pharmaceutical stocks that are being downgraded by analysts.
Keep Reading →
April 20 - Hedge Funds, News
In this piece, we will take a look at the ten biotechnology stocks to buy according to Ken Fisher's Fisher Asset Management.
Keep Reading →
April 13 - Hedge Funds, News
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade.
Keep Reading →
October 25 - Hedge Funds, News
Investors are practicing extreme caution amid uncertainty caused by the resurgence of COVID-19 all over the world.
Keep Reading →
September 1 - Hedge Funds, News
In this article, we discuss the 5 biotech stocks popular on Reddit.
Keep Reading →
August 19 - Hedge Funds, News
A whopping number of 13F filings filed with U.S.
Keep Reading →
July 19 - Hedge Funds, News
In this article we presented billionaire Steve Cohen's top 10 small-cap stock picks.
Keep Reading →
April 21 - Hedge Funds, News
In this article we discuss the billionaire Steve Cohen's top 5 small-cap stock picks.
Keep Reading →
April 21 - Hedge Funds, News
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market...
Keep Reading →
April 20 - Hedge Funds, News
We like healthcare and technology industries because of their above-average long-term growth prospects. Biotechnology is at the intersection of healthcare and technology.
Keep Reading →
February 8 - Hedge Funds, News
In this article we will take a look at whether hedge funds think BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) is a good investment right now.
Keep Reading →
December 18 - Hedge Funds, News
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Keep Reading →
September 28 - Hedge Funds, News
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Keep Reading →
July 18 - Hedge Funds, News
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Keep Reading →
June 15 - Hedge Funds, News
Hedge funds are known to underperform the bull markets but that's not because they are bad at investing.
Keep Reading →
December 11 - Hedge Funds, News
"Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much.
Keep Reading →
October 31 - Hedge Funds, News
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell...
Keep Reading →
June 11 - Hedge Funds, News
Is BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research.
Keep Reading →
May 3 - Hedge Funds, News
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset...
Keep Reading →
December 16 - Hedge Funds, News
Please follow RA Capital Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about RA Capital Management or update its stock...
Keep Reading →
April 3 - Hedge Funds
You can access the original SEC filing by clicking here.
Keep Reading →
June 6 - Hedge Funds
"World stock markets scaled fresh highs on Thursday, with key U.S. indexes lifted by rosy retailer results, while the U.S.
Keep Reading →
May 25 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech
You can access the original SEC filing by clicking here.
Keep Reading →
May 22 - Hedge Funds
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) has caught our attention in the biotech space as being a company that has had a bit of a strange start to the week.
Keep Reading →
March 1 - News, Stock Analysis
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.
Keep Reading →
December 5 - Hedge Funds, News
Julian Baker and Felix Baker's Baker Bros.
Keep Reading →
August 17 - Hedge Funds, News
Most securities that cost less than a dinner at a fast-food restaurant are considered to be too risky, with most intra-day traders or other investors usually avoiding these low...
Keep Reading →
May 31 - Hedge Funds, News
Biotech stocks pop and drop on the smallest whims and whispers, which makes the biotechnology sector one of the most rewarding and volatile sectors out there.
Keep Reading →
May 24 - Hedge Fund Analysis, Hedge Funds, News
Anders Hove and Bong Koh's VHCP Management owns a new position in BioCryst Pharmaceuticals, Inc.
Keep Reading →
March 29 - Hedge Funds, News
D. E. Shaw & Co, founded by billionaire David E. Shaw, has reported its position in BioCryst Pharmaceuticals, Inc.
Keep Reading →
March 16 - Hedge Funds, News
There are numerous exceptional money managers who have been able to consistently beat broader market benchmarks, which is just one reason why tracking the moves of elite hedge...
Keep Reading →
January 28 - Hedge Funds, News
The hedge fund industry closed in negative territory for 2015, marking the fourth year of decline for the industry since 1990.
Keep Reading →
January 22 - Commodities, Hedge Funds, News
Most investors monitor hedge funds’ 13F filings in order to identify high-potential stocks, and our research has provided evidence that these public filings bury inside numerous...
Keep Reading →
November 7 - Hedge Funds, News
It's been a disappointing day for investors of Gap Inc (NYSE:GPS), BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), Ruby Tuesday, Inc.
Keep Reading →
October 9 - Market Movers, News
According to a recent filing with the Securities and Exchange Commission, Peter Kolchinsky's RA Capital has initiated a position in Alcobra Ltd (NASDAQ:ADHD), acquiring some 1...
Keep Reading →
July 8 - Hedge Funds, News
With the SPDR S&P Biotech Index up 29% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Keep Reading →
July 29 - News
Alcoa Inc (NYSE:AA) will provide the informal kickoff to first-quarter earnings season Monday afternoon as the first Dow Jones industrial average component to report figures ...
Keep Reading →
April 8 - News
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shareholders have witnessed a decrease in hedge fund interest lately.
Keep Reading →
April 5 - News